Successful desensitization under antihistamine suppression in a case with urticaria due to osimertinib.

Gürgün Tuğçe Vural SolakKurtuluş AksuMusa TopelDilek Çuhadar ErçelebiSelma YeşilkayaŞenay DemirGözde Köycü Buhariİlkay Koca KalkanHale AteşSakine Nazik Bahçecioğlu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Here, a successful osimertinib desensitization in a patient with a history of osimertinib-related type 1 allergic reaction is reported. Osimertinib desensitization is a treatment option that should be considered in cases where treatment has to be ceased due to drug-related side effects.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
epidermal growth factor receptor
case report
combination therapy
drug induced
replacement therapy
adverse drug